Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy [clinicaltrials:NCT00121030]
Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy [clinicaltrials:NCT00121030]
Bio2RDF identifier
NCT00121030
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00121030
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... r anemia due to chemotherapy.
brief title [clinicaltrials_vocabulary:brief-title]
Treatment for Patients With Gy ...... rom Anemia Due to Chemotherapy
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2003-12-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-06-30T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Gynecological Malignancies
darbepoetin alfa
ovarian cancer
uterine cancer
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2007-12-20T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00121030
official title [clinicaltrials_vocabulary:official-title]
An Open-Label, Randomized Phas ...... for Anemia Due to Chemotherapy
org study id [clinicaltrials_vocabulary:org-study-id]
20,020,166
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2007-12-01T00:00:00Z
identifier
clinicaltrials:NCT00121030
title
Treatment for Patients With Gy ...... rom Anemia Due to Chemotherapy
@en
type
label
Treatment for Patients With Gy ...... y [clinicaltrials:NCT00121030]
@en